NCT04045470
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Lymphoma, T-Cell, Cutaneous
Explore clinical trials studying Lymphoma, T-Cell, Cutaneous. Study availability and eligibility vary by location and protocol.
389 public trials
42 recruiting studies
Lymphoma, T-Cell, Cutaneous trial results
NCT06698822
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT06860880
- Conditions
- Behavior, Blood Protein Disorders, Cardiovascular Diseases, +37 more
- Locations
-
- North Carolina Basnight Cancer Hospital Chapel Hill, North Carolina, United States
Recruiting
Registry of Older Patients With Cancer
NCT01137825
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +98 more
- Locations
-
- Seby B. Jones Cancer Center Boone, North Carolina, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
- East Carolina University Greenville, North Carolina, United States
- Pardee Cancer Center Hendersonville, North Carolina, United States
Recruiting
Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
NCT05313243
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Yale Smilow Cancer Hospital New Haven, Connecticut, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT03017820
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bone Marrow Diseases, +46 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Recruiting
A Registry for People With T-cell Lymphoma
NCT05978141
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive, +54 more
- Locations
-
- City of Hope Cancer Center (Data collection only) Duarte, California, United States
- UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only) San Diego, California, United States
- University of California San Francisco (Data collection only) San Francisco, California, United States
- Stanford University Medical Center (Data collection only) Stanford, California, United States
Recruiting
Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
NCT05956041
- Conditions
- Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
NCT03932279
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
NCT05680558
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Columbia University Irving Medical Center New York, United States